{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:16:24Z","timestamp":1790799384362,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The restrictive cardiomyopathies constitute a heterogeneous group of myocardial diseases with a different pathogenesis and overlapping clinical presentations. Diagnosing them frequently poses a challenge. Echocardiography, electrocardiograms and laboratory tests may show non-specific changes. In this context, cardiac magnetic resonance (CMR) may play a crucial role in defining the diagnosis and guiding treatments, by offering a robust myocardial characterization based on the inherent magnetic properties of abnormal tissues, thus limiting the use of endomyocardial biopsy. In this review article, we explore the role of CMR in the assessment of a wide range of myocardial diseases causing restrictive patterns, from iron overload to cardiac amyloidosis, endomyocardial fibrosis or radiation-induced heart disease. Here, we emphasize the incremental value of novel relaxometric techniques such as T1 and T2 mapping, which may recognize different storage diseases based on the intrinsic magnetic properties of the accumulating metabolites, with or without the use of gadolinium-based contrast agents. We illustrate the importance of these CMR techniques and their great support when contrast media administration is contraindicated. Finally, we describe the useful role of cardiac computed tomography for diagnosis and management of restrictive cardiomyopathies when CMR is contraindicated.<\/jats:p>","DOI":"10.1007\/s11547-020-01287-8","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T06:02:54Z","timestamp":1600927374000},"page":"1072-1086","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cardiovascular magnetic resonance (CMR) in restrictive cardiomyopathies"],"prefix":"10.1007","volume":"125","author":[{"given":"Nicola","family":"Galea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesualdo","family":"Polizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Cundari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Figuera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8865-8637","authenticated-orcid":false,"given":"Riccardo","family":"Faletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,24]]},"reference":[{"key":"1287_CR1","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.jacc.2018.01.016","volume":"71","author":"NL Pereira","year":"2018","unstructured":"Pereira NL, Grogan M, Dec GW (2018) Spectrum of restrictive and infiltrative\u00a0cardiomyopathies: part 1 of a 2-part series. J Am Coll Cardiol 71:1130\u20131148. https:\/\/doi.org\/10.1016\/j.jacc.2018.01.016","journal-title":"J Am Coll Cardiol"},{"key":"1287_CR2","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jcmg.2013.01.011","volume":"6","author":"SK White","year":"2013","unstructured":"White SK, Sado DM, Fontana M et al (2013) T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging 6:955\u2013962. https:\/\/doi.org\/10.1016\/j.jcmg.2013.01.011","journal-title":"JACC Cardiovasc Imaging"},{"key":"1287_CR3","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/RTI.0000000000000199","volume":"31","author":"F Muehlberg","year":"2016","unstructured":"Muehlberg F, Toepper A, Fritschi S et al (2016) Magnetic resonance imaging applications on infiltrative cardiomyopathies. J Thorac Imaging 31:336\u2013347. https:\/\/doi.org\/10.1097\/RTI.0000000000000199","journal-title":"J Thorac Imaging"},{"key":"1287_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.07.015","author":"S Dorbala","year":"2019","unstructured":"Dorbala S, Cuddy S, Falk RH (2019) How to image cardiac amyloidosis: a practical approach. JACC Cardiovasc Imaging. https:\/\/doi.org\/10.1016\/j.jcmg.2019.07.015","journal-title":"JACC Cardiovasc Imaging"},{"key":"1287_CR5","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1016\/j.jcmg.2019.06.023","volume":"12","author":"M Fontana","year":"2019","unstructured":"Fontana M, \u0106orovi\u0107 A, Scully P, Moon JC (2019) Myocardial amyloidosis: the exemplar interstitial disease. JACC Cardiovasc Imaging 12:2345\u20132356. https:\/\/doi.org\/10.1016\/j.jcmg.2019.06.023","journal-title":"JACC Cardiovasc Imaging"},{"key":"1287_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1532-429X-14-88","volume":"14","author":"M Fontana","year":"2012","unstructured":"Fontana M, White SK, Banypersad SM et al (2012) Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson 14:88. https:\/\/doi.org\/10.1186\/1532-429X-14-88","journal-title":"J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson"},{"key":"1287_CR7","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","volume":"387","author":"AD Wechalekar","year":"2016","unstructured":"Wechalekar AD, Gillmore JD, Hawkins PN (2016) Systemic amyloidosis. The Lancet 387:2641\u20132654. https:\/\/doi.org\/10.1016\/S0140-6736(15)01274-X","journal-title":"The Lancet"},{"key":"1287_CR8","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","volume":"135","author":"MS Maurer","year":"2017","unstructured":"Maurer MS, Elliott P, Comenzo R et al (2017) Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. Circulation 135:1357\u20131377. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024438","journal-title":"Circulation"},{"key":"1287_CR9","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1182\/blood-2012-03-413112","volume":"119","author":"G Merlini","year":"2012","unstructured":"Merlini G (2012) CyBorD: stellar response rates in AL amyloidosis. Blood 119:4343\u20134345. https:\/\/doi.org\/10.1182\/blood-2012-03-413112","journal-title":"Blood"},{"key":"1287_CR10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/ehf2.12382","volume":"6","author":"Y Shintani","year":"2019","unstructured":"Shintani Y, Okada A, Morita Y et al (2019) Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy. ESC Heart Fail 6:232\u2013236. https:\/\/doi.org\/10.1002\/ehf2.12382","journal-title":"ESC Heart Fail"},{"key":"1287_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","volume":"111","author":"AM Maceira","year":"2005","unstructured":"Maceira AM, Joshi J, Prasad SK et al (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111:186\u2013193. https:\/\/doi.org\/10.1161\/01.CIR.0000152819.97857.9D","journal-title":"Circulation"},{"key":"1287_CR12","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","volume":"70","author":"A Martinez-Naharro","year":"2017","unstructured":"Martinez-Naharro A, Treibel TA, Abdel-Gadir A et al (2017) Magnetic resonance in transthyretin\u00a0cardiac amyloidosis. J Am Coll Cardiol 70:466\u2013477. https:\/\/doi.org\/10.1016\/j.jacc.2017.05.053","journal-title":"J Am Coll Cardiol"},{"key":"1287_CR13","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","volume":"132","author":"M Fontana","year":"2015","unstructured":"Fontana M, Pica S, Reant P et al (2015) Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 132:1570\u20131579. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.016567","journal-title":"Circulation"},{"key":"1287_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","volume":"13","author":"A Baggiano","year":"2020","unstructured":"Baggiano A, Boldrini M, Martinez-Naharro A et al (2020) Noncontrast magnetic resonance for the\u00a0diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 13:69\u201380. https:\/\/doi.org\/10.1016\/j.jcmg.2019.03.026","journal-title":"JACC Cardiovasc Imaging"},{"key":"1287_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","volume":"6","author":"SM Banypersad","year":"2013","unstructured":"Banypersad SM, Sado DM, Flett AS et al (2013) Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 6:34\u201339. https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.978627","journal-title":"Circ Cardiovasc Imaging"},{"key":"1287_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1148\/radiol.2015141744","volume":"277","author":"M Fontana","year":"2015","unstructured":"Fontana M, Banypersad SM, Treibel TA et al (2015) Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study. Radiology 277:388\u2013397. https:\/\/doi.org\/10.1148\/radiol.2015141744","journal-title":"Radiology"},{"key":"1287_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","volume":"36","author":"SM Banypersad","year":"2015","unstructured":"Banypersad SM, Fontana M, Maestrini V et al (2015) T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J 36:244\u2013251. https:\/\/doi.org\/10.1093\/eurheartj\/ehu444","journal-title":"Eur Heart J"},{"key":"1287_CR18","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1016\/j.jacc.2018.03.536","volume":"71","author":"T Kotecha","year":"2018","unstructured":"Kotecha T, Martinez-Naharro A, Treibel TA et al (2018) Myocardial edema and prognosis in\u00a0amyloidosis. J Am Coll Cardiol 71:2919\u20132931. https:\/\/doi.org\/10.1016\/j.jacc.2018.03.536","journal-title":"J Am Coll Cardiol"},{"key":"1287_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s11886-019-1238-1","volume":"21","author":"P Mankad","year":"2019","unstructured":"Mankad P, Mitchell B, Birnie D, Kron J (2019) Cardiac sarcoidosis. Curr Cardiol Rep 21:152. https:\/\/doi.org\/10.1007\/s11886-019-1238-1","journal-title":"Curr Cardiol Rep"},{"key":"1287_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.amjcard.2018.10.021","volume":"123","author":"JL Tan","year":"2019","unstructured":"Tan JL, Fong HK, Birati EY, Han Y (2019) Cardiac sarcoidosis. Am J Cardiol 123:513\u2013522. https:\/\/doi.org\/10.1016\/j.amjcard.2018.10.021","journal-title":"Am J Cardiol"},{"key":"1287_CR21","doi-asserted-by":"publisher","first-page":"e005001","DOI":"10.1161\/CIRCIMAGING.116.005001","volume":"9","author":"E Hulten","year":"2016","unstructured":"Hulten E, Agarwal V, Cahill M et al (2016) Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis. Circ Cardiovasc Imaging 9:e005001. https:\/\/doi.org\/10.1161\/CIRCIMAGING.116.005001","journal-title":"Circ Cardiovasc Imaging"},{"key":"1287_CR22","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/ehjci\/jex340","volume":"19","author":"EC Wicks","year":"2018","unstructured":"Wicks EC, Menezes LJ, Barnes A et al (2018) Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging 19:757\u2013767. https:\/\/doi.org\/10.1093\/ehjci\/jex340","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1287_CR23","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1161\/CIRCULATIONAHA.114.009789","volume":"130","author":"SF Nagueh","year":"2014","unstructured":"Nagueh SF (2014) Anderson-Fabry disease and other lysosomal storage disorders. Circulation 130:1081\u20131090. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.009789","journal-title":"Circulation"},{"key":"1287_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.carpath.2018.11.002","volume":"39","author":"V Nair","year":"2019","unstructured":"Nair V, Belanger EC, Veinot JP (2019) Lysosomal storage disorders affecting the heart: a review. Cardiovasc Pathol Off J Soc Cardiovasc Pathol 39:12\u201324. https:\/\/doi.org\/10.1016\/j.carpath.2018.11.002","journal-title":"Cardiovasc Pathol Off J Soc Cardiovasc Pathol"},{"key":"1287_CR25","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.jcmg.2018.11.039","volume":"12","author":"R Perry","year":"2019","unstructured":"Perry R, Shah R, Saiedi M et al (2019) The role of cardiac imaging in the diagnosis and management of Anderson-Fabry disease. JACC Cardiovasc Imaging 12:1230\u20131242. https:\/\/doi.org\/10.1016\/j.jcmg.2018.11.039","journal-title":"JACC Cardiovasc Imaging"},{"key":"1287_CR26","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","volume":"24","author":"JCC Moon","year":"2003","unstructured":"Moon JCC, Sachdev B, Elkington AG et al (2003) Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 24:2151\u20132155. https:\/\/doi.org\/10.1016\/j.ehj.2003.09.017","journal-title":"Eur Heart J"},{"key":"1287_CR27","doi-asserted-by":"publisher","first-page":"W97","DOI":"10.2214\/AJR.08.1201","volume":"192","author":"F De Cobelli","year":"2009","unstructured":"De Cobelli F, Esposito A, Belloni E et al (2009) Delayed-enhanced cardiac MRI for differentiation of Fabry\u2019s disease from symmetric hypertrophic cardiomyopathy. AJR Am J Roentgenol 192:W97\u2013102. https:\/\/doi.org\/10.2214\/AJR.08.1201","journal-title":"AJR Am J Roentgenol"},{"key":"1287_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007124","author":"P Aguiar","year":"2018","unstructured":"Aguiar P, Azevedo O, Pinto R et al (2018) Biomarkers of myocardial fibrosis: revealing the natural history of fibrogenesis in Fabry disease cardiomyopathy. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.117.007124","journal-title":"J Am Heart Assoc"},{"key":"1287_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1148\/radiol.2019191385","volume":"294","author":"K Hanneman","year":"2020","unstructured":"Hanneman K, Karur GR, Wasim S et al (2020) Left ventricular hypertrophy and late gadolinium enhancement at cardiac MRI are associated with adverse cardiac events in fabry disease. Radiology 294:42\u201349. https:\/\/doi.org\/10.1148\/radiol.2019191385","journal-title":"Radiology"},{"key":"1287_CR30","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.jcmg.2018.03.020","volume":"12","author":"S Nordin","year":"2019","unstructured":"Nordin S, Kozor R, Medina-Menacho K et al (2019) proposed stages of myocardial phenotype development in Fabry\u00a0disease. JACC Cardiovasc Imaging 12:1673\u20131683. https:\/\/doi.org\/10.1016\/j.jcmg.2018.03.020","journal-title":"JACC Cardiovasc Imaging"},{"key":"1287_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","volume":"6","author":"DM Sado","year":"2013","unstructured":"Sado DM, White SK, Piechnik SK et al (2013) Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging 6:392\u2013398. https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.000070","journal-title":"Circ Cardiovasc Imaging"},{"key":"1287_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12968-014-0099-4","volume":"16","author":"S Pica","year":"2014","unstructured":"Pica S, Sado DM, Maestrini V et al (2014) Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson 16:99. https:\/\/doi.org\/10.1186\/s12968-014-0099-4","journal-title":"J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson"},{"key":"1287_CR33","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1161\/CIRCIMAGING.113.000482","volume":"6","author":"RB Thompson","year":"2013","unstructured":"Thompson RB, Chow K, Khan A et al (2013) T1 mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex. Circ Cardiovasc Imaging 6:637\u2013645. https:\/\/doi.org\/10.1161\/CIRCIMAGING.113.000482","journal-title":"Circ Cardiovasc Imaging"},{"key":"1287_CR34","doi-asserted-by":"publisher","first-page":"e009052","DOI":"10.1161\/JAHA.118.009052","volume":"7","author":"A Frustaci","year":"2018","unstructured":"Frustaci A, Verardo R, Grande C et al (2018) Immune-mediated myocarditis in Fabry disease cardiomyopathy. J Am Heart Assoc 7:e009052. https:\/\/doi.org\/10.1161\/JAHA.118.009052","journal-title":"J Am Heart Assoc"},{"key":"1287_CR35","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1148\/radiol.2018172613","volume":"288","author":"GR Karur","year":"2018","unstructured":"Karur GR, Robison S, Iwanochko RM et al (2018) Use of myocardial T1 mapping at 3.0 T to differentiate Anderson-Fabry disease from hypertrophic cardiomyopathy. Radiology 288:398\u2013406. https:\/\/doi.org\/10.1148\/radiol.2018172613","journal-title":"Radiology"},{"key":"1287_CR36","doi-asserted-by":"publisher","first-page":"e008424","DOI":"10.1161\/CIRCIMAGING.118.008424","volume":"12","author":"A Camporeale","year":"2019","unstructured":"Camporeale A, Pieroni M, Pieruzzi F et al (2019) Predictors of clinical evolution in prehypertrophic Fabry disease. Circ Cardiovasc Imaging 12:e008424. https:\/\/doi.org\/10.1161\/CIRCIMAGING.118.008424","journal-title":"Circ Cardiovasc Imaging"},{"key":"1287_CR37","doi-asserted-by":"publisher","first-page":"e010171","DOI":"10.1161\/CIRCIMAGING.119.010171","volume":"13","author":"JB Augusto","year":"2020","unstructured":"Augusto JB, Nordin S, Vijapurapu R et al (2020) Myocardial edema, myocyte injury, and disease severity in Fabry disease. Circ Cardiovasc Imaging 13:e010171. https:\/\/doi.org\/10.1161\/CIRCIMAGING.119.010171","journal-title":"Circ Cardiovasc Imaging"},{"key":"1287_CR38","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/heartjnl-2018-313699","volume":"105","author":"R Vijapurapu","year":"2019","unstructured":"Vijapurapu R, Nordin S, Baig S et al (2019) Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease. Heart Br Card Soc 105:470\u2013476. https:\/\/doi.org\/10.1136\/heartjnl-2018-313699","journal-title":"Heart Br Card Soc"},{"key":"1287_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12968-019-0557-0","volume":"21","author":"S Mathur","year":"2019","unstructured":"Mathur S, Dreisbach JG, Karur GR et al (2019) Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson 21:45. https:\/\/doi.org\/10.1186\/s12968-019-0557-0","journal-title":"J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson"},{"key":"1287_CR40","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jacc.2010.03.083","volume":"56","author":"P Gujja","year":"2010","unstructured":"Gujja P, Rosing DR, Tripodi DJ, Shizukuda Y (2010) Iron overload cardiomyopathy: better understanding of an increasing disorder. J Am Coll Cardiol 56:1001\u20131012. https:\/\/doi.org\/10.1016\/j.jacc.2010.03.083","journal-title":"J Am Coll Cardiol"},{"key":"1287_CR41","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.111.050773","volume":"124","author":"DT Kremastinos","year":"2011","unstructured":"Kremastinos DT, Farmakis D (2011) Iron overload cardiomyopathy in clinical practice. Circulation 124:2253\u20132263. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.050773","journal-title":"Circulation"},{"key":"1287_CR42","doi-asserted-by":"publisher","first-page":"W266","DOI":"10.2214\/AJR.12.9633","volume":"200","author":"KJ Giesbrandt","year":"2013","unstructured":"Giesbrandt KJ, Bolan CW, Shapiro BP et al (2013) Diffuse diseases of the myocardium: MRI-pathologic review of nondilated cardiomyopathies. AJR Am J Roentgenol 200:W266\u2013273. https:\/\/doi.org\/10.2214\/AJR.12.9633","journal-title":"AJR Am J Roentgenol"},{"key":"1287_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-017-0389-8","author":"DR Messroghli","year":"2017","unstructured":"Messroghli DR, Moon JC, Ferreira VM et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. https:\/\/doi.org\/10.1186\/s12968-017-0389-8","journal-title":"J Cardiovasc Magn Reson"},{"key":"1287_CR44","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s00330-019-06364-9","volume":"30","author":"P Triadyaksa","year":"2020","unstructured":"Triadyaksa P, Kuijpers D, Akinci D\u2019Antonoli T et al (2020) Early detection of heart function abnormality by native T1: a comparison of two T1 quantification methods. Eur Radiol 30:652\u2013662. https:\/\/doi.org\/10.1007\/s00330-019-06364-9","journal-title":"Eur Radiol"},{"key":"1287_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jmri.25720","volume":"47","author":"R Shah","year":"2018","unstructured":"Shah R, Nucifora G, Perry R, Selvanayagam JB (2018) Noninvasive imaging in cardiac deposition diseases. J Magn Reson Imaging JMRI 47:44\u201359. https:\/\/doi.org\/10.1002\/jmri.25720","journal-title":"J Magn Reson Imaging JMRI"},{"key":"1287_CR46","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1148\/radiol.2015150341","volume":"279","author":"K Hanneman","year":"2016","unstructured":"Hanneman K, Nguyen ET, Thavendiranathan P et al (2016) Quantification of myocardial extracellular volume fraction with cardiac MR imaging in thalassemia major. Radiology 279:720\u2013730. https:\/\/doi.org\/10.1148\/radiol.2015150341","journal-title":"Radiology"},{"key":"1287_CR47","doi-asserted-by":"publisher","first-page":"e0192890","DOI":"10.1371\/journal.pone.0192890","volume":"13","author":"C Torlasco","year":"2018","unstructured":"Torlasco C, Cassinerio E, Roghi A et al (2018) Role of T1 mapping as a complementary tool to T2* for non-invasive cardiac iron overload assessment. PLoS ONE 13:e0192890. https:\/\/doi.org\/10.1371\/journal.pone.0192890","journal-title":"PLoS ONE"},{"key":"1287_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/ehjci\/jex012","volume":"19","author":"A Pepe","year":"2018","unstructured":"Pepe A, Meloni A, Rossi G et al (2018) Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach. Eur Heart J Cardiovasc Imaging 19:299\u2013309. https:\/\/doi.org\/10.1093\/ehjci\/jex012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1287_CR49","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1161\/CIRCULATIONAHA.115.021178","volume":"133","author":"A Grimaldi","year":"2016","unstructured":"Grimaldi A, Mocumbi AO, Freers J et al (2016) Tropical endomyocardial fibrosis: natural history, challenges, and perspectives. Circulation 133:2503\u20132515. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.021178","journal-title":"Circulation"},{"key":"1287_CR50","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/CIRCIMAGING.110.950675","volume":"4","author":"VMC Salemi","year":"2011","unstructured":"Salemi VMC, Rochitte CE, Shiozaki AA et al (2011) Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients. Circ Cardiovasc Imaging 4:304\u2013311. https:\/\/doi.org\/10.1161\/CIRCIMAGING.110.950675","journal-title":"Circ Cardiovasc Imaging"},{"key":"1287_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/heartjnl-2015-308765","volume":"102","author":"DM Gujral","year":"2016","unstructured":"Gujral DM, Lloyd G, Bhattacharyya S (2016) Radiation-induced valvular heart disease. Heart Br Card Soc 102:269\u2013276. https:\/\/doi.org\/10.1136\/heartjnl-2015-308765","journal-title":"Heart Br Card Soc"},{"key":"1287_CR52","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.7150\/ijbs.35460","volume":"15","author":"H Wang","year":"2019","unstructured":"Wang H, Wei J, Zheng Q et al (2019) Radiation-induced heart disease: a review of classification, mechanism and prevention. Int J Biol Sci 15:2128\u20132138. https:\/\/doi.org\/10.7150\/ijbs.35460","journal-title":"Int J Biol Sci"},{"key":"1287_CR53","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jcmg.2018.04.028","volume":"11","author":"MY Desai","year":"2018","unstructured":"Desai MY, Jellis CL, Kotecha R et al (2018) Radiation-associated cardiac disease: a practical approach to diagnosis and management. JACC Cardiovasc Imaging 11:1132\u20131149. https:\/\/doi.org\/10.1016\/j.jcmg.2018.04.028","journal-title":"JACC Cardiovasc Imaging"},{"key":"1287_CR54","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/ehjci\/jet123","volume":"14","author":"P Lancellotti","year":"2013","unstructured":"Lancellotti P, Nkomo VT, Badano LP et al (2013) Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging 14:721\u2013740. https:\/\/doi.org\/10.1093\/ehjci\/jet123","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1287_CR55","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.crad.2014.08.010","volume":"69","author":"R Umezawa","year":"2014","unstructured":"Umezawa R, Ota H, Takanami K et al (2014) MRI findings of radiation-induced myocardial damage in patients with oesophageal cancer. Clin Radiol 69:1273\u20131279. https:\/\/doi.org\/10.1016\/j.crad.2014.08.010","journal-title":"Clin Radiol"},{"key":"1287_CR56","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.ijrobp.2009.12.054","volume":"79","author":"W Machann","year":"2011","unstructured":"Machann W, Beer M, Breunig M et al (2011) Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin\u2019s disease. Int J Radiat Oncol Biol Phys 79:1117\u20131123. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.12.054","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1287_CR57","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Mu\u00f1oz D et al (2016) 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: & #x2002;the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 37:2768\u20132801. https:\/\/doi.org\/10.1093\/eurheartj\/ehw211","journal-title":"Eur Heart J"},{"key":"1287_CR58","doi-asserted-by":"publisher","first-page":"e5932","DOI":"10.1097\/MD.0000000000005932","volume":"96","author":"X-F Zhuang","year":"2017","unstructured":"Zhuang X-F, Yang Y-M, Sun X-L et al (2017) Late onset radiation-induced constrictive pericarditis and cardiomyopathy after radiotherapy: a case report. Medicine (Baltimore) 96:e5932. https:\/\/doi.org\/10.1097\/MD.0000000000005932","journal-title":"Medicine (Baltimore)"},{"key":"1287_CR59","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jccase.2018.06.001","volume":"18","author":"N Mukai-Yatagai","year":"2018","unstructured":"Mukai-Yatagai N, Haruki N, Kinugasa Y et al (2018) Assessment of myocardial fibrosis using T1-mapping and extracellular volume measurement on cardiac magnetic resonance imaging for the diagnosis of radiation-induced cardiomyopathy. J Cardiol Cases 18:132\u2013135. https:\/\/doi.org\/10.1016\/j.jccase.2018.06.001","journal-title":"J Cardiol Cases"},{"key":"1287_CR60","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/ccd.28692","volume":"95","author":"JA Goldstein","year":"2020","unstructured":"Goldstein JA, Kern MJ (2020) Hemodynamics of constrictive pericarditis and restrictive cardiomyopathy. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv 95:1240\u20131248. https:\/\/doi.org\/10.1002\/ccd.28692","journal-title":"Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv"},{"key":"1287_CR61","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.jacc.2016.01.076","volume":"67","author":"MJ Garcia","year":"2016","unstructured":"Garcia MJ (2016) Constrictive pericarditis versus restrictive\u00a0cardiomyopathy? J Am Coll Cardiol 67:2061\u20132076. https:\/\/doi.org\/10.1016\/j.jacc.2016.01.076","journal-title":"J Am Coll Cardiol"},{"key":"1287_CR62","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.crad.2011.05.020","volume":"67","author":"A Gupta","year":"2012","unstructured":"Gupta A, Singh Gulati G, Seth S, Sharma S (2012) Cardiac MRI in restrictive cardiomyopathy. Clin Radiol 67:95\u2013105. https:\/\/doi.org\/10.1016\/j.crad.2011.05.020","journal-title":"Clin Radiol"},{"key":"1287_CR63","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s10554-015-0648-4","volume":"31","author":"GD Aquaro","year":"2015","unstructured":"Aquaro GD, Barison A, Cagnolo A et al (2015) Role of tissue characterization by cardiac magnetic resonance in the diagnosis of constrictive pericarditis. Int J Cardiovasc Imaging 31:1021\u20131031. https:\/\/doi.org\/10.1007\/s10554-015-0648-4","journal-title":"Int J Cardiovasc Imaging"},{"key":"1287_CR64","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/jmri.20259","volume":"21","author":"M Francone","year":"2005","unstructured":"Francone M, Dymarkowski S, Kalantzi M, Bogaert J (2005) Real-time cine MRI of ventricular septal motion: a novel approach to assess ventricular coupling. J Magn Reson Imaging JMRI 21:305\u2013309. https:\/\/doi.org\/10.1002\/jmri.20259","journal-title":"J Magn Reson Imaging JMRI"},{"key":"1287_CR65","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s00330-005-0009-0","volume":"16","author":"M Francone","year":"2006","unstructured":"Francone M, Dymarkowski S, Kalantzi M et al (2006) Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy. Eur Radiol 16:944\u2013951. https:\/\/doi.org\/10.1007\/s00330-005-0009-0","journal-title":"Eur Radiol"},{"key":"1287_CR66","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.jtcvs.2015.12.035","volume":"151","author":"JA Power","year":"2016","unstructured":"Power JA, Thompson DV, Rayarao G et al (2016) Cardiac magnetic resonance radiofrequency tissue tagging for diagnosis of constrictive pericarditis: a proof of concept study. J Thorac Cardiovasc Surg 151:1348\u20131355. https:\/\/doi.org\/10.1016\/j.jtcvs.2015.12.035","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1287_CR67","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ejrad.2007.03.008","volume":"65","author":"BR Annuar","year":"2008","unstructured":"Annuar BR, Liew CK, Chin SP et al (2008) Assessment of global and regional left ventricular function using 64-slice multislice computed tomography and 2D echocardiography: a comparison with cardiac magnetic resonance. Eur J Radiol 65:112\u2013119. https:\/\/doi.org\/10.1016\/j.ejrad.2007.03.008","journal-title":"Eur J Radiol"},{"key":"1287_CR68","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2463\/mrms.3.145","volume":"3","author":"N Oyama","year":"2004","unstructured":"Oyama N, Oyama N, Komuro K et al (2004) Computed tomography and magnetic resonance imaging of the pericardium: anatomy and pathology. Magn Reson Med Sci MRMS Off J Jpn Soc Magn Reson Med 3:145\u2013152. https:\/\/doi.org\/10.2463\/mrms.3.145","journal-title":"Magn Reson Med Sci MRMS Off J Jpn Soc Magn Reson Med"},{"key":"1287_CR69","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.104.529511","volume":"113","author":"BL Gerber","year":"2006","unstructured":"Gerber BL, Belge B, Legros GJ et al (2006) Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance. Circulation 113:823\u2013833. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.529511","journal-title":"Circulation"},{"key":"1287_CR70","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1148\/radiol.2017162945","volume":"287","author":"S Chang","year":"2018","unstructured":"Chang S, Han K, Youn J-C et al (2018) Utility of dual-energy ct-based monochromatic imaging in the assessment of myocardial delayed enhancement in patients with cardiomyopathy. Radiology 287:442\u2013451. https:\/\/doi.org\/10.1148\/radiol.2017162945","journal-title":"Radiology"},{"key":"1287_CR71","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jcct.2015.07.001","volume":"9","author":"TA Treibel","year":"2015","unstructured":"Treibel TA, Bandula S, Fontana M et al (2015) Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis. J Cardiovasc Comput Tomogr 9:585\u2013592. https:\/\/doi.org\/10.1016\/j.jcct.2015.07.001","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"1287_CR72","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jcmg.2015.10.024","volume":"9","author":"A Esposito","year":"2016","unstructured":"Esposito A, Palmisano A, Antunes S et al (2016) Cardiac CT with delayed enhancement in\u00a0the characterization of ventricular tachycardia structural substrate: relationship between CT-segmented scar and electro-anatomic mapping. JACC Cardiovasc Imaging 9:822\u2013832. https:\/\/doi.org\/10.1016\/j.jcmg.2015.10.024","journal-title":"JACC Cardiovasc Imaging"},{"key":"1287_CR73","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1148\/radiol.2016151289","volume":"280","author":"H-J Lee","year":"2016","unstructured":"Lee H-J, Im DJ, Youn J-C et al (2016) Myocardial extracellular volume fraction with dual-energy equilibrium contrast-enhanced cardiac CT in nonischemic cardiomyopathy: a prospective comparison with cardiac MR imaging. Radiology 280:49\u201357. https:\/\/doi.org\/10.1148\/radiol.2016151289","journal-title":"Radiology"},{"key":"1287_CR74","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s11547-019-01108-7","volume":"125","author":"A Palmisano","year":"2020","unstructured":"Palmisano A, Vignale D, Benedetti G et al (2020) Late iodine enhancement cardiac computed tomography for detection of myocardial scars: impact of experience in the clinical practice. Radiol Med (Torino) 125:128\u2013136. https:\/\/doi.org\/10.1007\/s11547-019-01108-7","journal-title":"Radiol Med (Torino)"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-020-01287-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-020-01287-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-020-01287-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T06:10:31Z","timestamp":1632463831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-020-01287-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":74,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1287"],"URL":"https:\/\/doi.org\/10.1007\/s11547-020-01287-8","relation":{},"ISSN":["0033-8362","1826-6983"],"issn-type":[{"value":"0033-8362","type":"print"},{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,24]]},"assertion":[{"value":"9 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}